Position in VRTX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$26,771,859
-$14,249,513 QoQ
Shares Held
59,954
-33.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $266,175,967 across 93 Biotechnology names. VRTX ranks #2 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
3,388,920 | $145,350,778 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
59,954 | $26,771,859 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
166,617 | $10,768,456 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,316 | $9,515,834 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
29,569 | $8,781,105 | |
| 6 | ARGX |
Argenx SE
|
9,275 | $6,773,068 | |
| 7 | GMAB |
Genmab A/S
|
224,144 | $6,013,783 | |
| 8 | INSM |
INSMED Inc
|
34,258 | $5,601,868 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,771,859 | 59,954 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $41,021,372 | 90,483 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $35,188,854 | 89,850 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $41,132,473 | 92,391 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $41,353,691 | 85,297 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $32,161,635 | 79,865 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $94,909,340 | 204,071 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $178,279,526 | 380,354 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $159,872,522 | 382,461 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $157,628,372 | 387,398 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $175,409,792 | 504,428 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $179,886,186 | 511,171 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $169,772,003 | 538,839 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $116,006,391 | 401,712 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $112,300,405 | 387,858 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,135,686 | 7,579 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,274,316 | 4,883 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $399,891 | 1,821 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,771 | 109 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $29,841 | 148 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $35,886 | 167 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $31,433 | 133 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $42,178 | 155 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $89,705 | 309 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $16,180 | 68 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||